HCW Biologics Inc.
HCWB
$2.06
$0.073.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 422.10K | 832.90K | 1.45M | 2.57M | 3.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 422.10K | 832.90K | 1.45M | 2.57M | 3.50M |
| Cost of Revenue | 337.60K | 666.20K | 1.10M | 1.61M | 2.36M |
| Gross Profit | 84.40K | 166.60K | 345.70K | 959.40K | 1.13M |
| SG&A Expenses | 10.21M | 10.90M | 20.65M | 24.15M | 29.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.60M | 16.41M | 27.39M | 32.04M | 39.28M |
| Operating Income | -15.18M | -15.57M | -25.95M | -29.47M | -35.78M |
| Income Before Tax | -12.05M | -11.40M | -24.75M | -30.02M | -37.33M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.05 | -11.40 | -24.75 | -30.02 | -37.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.05M | -11.40M | -24.75M | -30.02M | -37.33M |
| EBIT | -15.18M | -15.57M | -25.95M | -29.47M | -35.78M |
| EBITDA | -13.61M | -14.05M | -24.59M | -28.29M | -35.01M |
| EPS Basic | -13.96 | -16.07 | -25.44 | -31.50 | -40.18 |
| Normalized Basic EPS | -7.39 | -8.98 | -16.93 | -19.60 | -24.25 |
| EPS Diluted | -13.96 | -16.07 | -25.44 | -31.50 | -40.18 |
| Normalized Diluted EPS | -7.39 | -8.98 | -16.93 | -19.60 | -24.25 |
| Average Basic Shares Outstanding | 6.21M | 4.90M | 4.07M | 3.88M | 3.72M |
| Average Diluted Shares Outstanding | 6.21M | 4.90M | 4.07M | 3.88M | 3.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |